This is a history of that my www.alphataumedical.com platform technology that is the most effective therapy for all solid tumor with the bonuses of no, there cannot be, side effects, dissolving tumors in days and its alpha particles uniquely are the only type of radiation that cuts both helices of the tumor’s DNA.

1. 8/9/2017 8:35 PM Alpha Tau History Page 1 of 4
ISRAELIS DOING THEIMPOSSIBLE: RESULTS:
SUCCESSFUL CANCER THERAPY
By Howard D Sterling
Its 1903: Mme. Marie Curie justwon her firstNobel Prizefor discovering
radioactive alpha particles which are the nucleus of helium, two protons and two
neutrons. We see her obsessed with using her alpha particles for effective cancer
therapy---with no success.
1903-2003: Scientists realizewhy alpha particles should work as effective cancer
therapy and why they cannot work While it is true the alpha particles: (i) are
emitted with great power from radioactive molecules such as Radium 224; (ii)
have a billion x billion times the mass of electrons used in beta radiation (used in
prostatecancer beta radiation brachytherapy seeds) and (ii) are infinitely heavier
than photons, X-ray gamma radiation, emitted in conventional linear accelerator.
The scientists also saw why alpha particles could not be effective cancer therapy;
the alpha particles only traveled a micron or two, (1-2 millionths of a centimeter)
fromtheir emitters, not enough to causeeffective damage to cancerous tumors.
Scientists gave up on alpha particles for cancer. It was considered impossible.
Its 2003: Two eminent scientists at Tel Aviv University, ProfessorIsaac Kelson, a
basic physicistand Professor Yona Keisari, a biologist in the medical schooltook
on the impossibility of alpha particles for cancer and made them work
successfully as cancer therapies, firstin animals then in humans. They did the
impossible.
How Did They Do the Impossible? ProfessorsKelson and Keisarirealized that,
although the alpha particles could only travel a micron or two, as a fact of nature,
the emitters, such as radium 224, moved backward by recoil millimeters, about
10,000 times as far, enough to do heavy damage to tumors. What is recoil?
Imagineshooting a small bullet (the equivalent of the alpha particles) froma big
rifle (the equivalent of the alpha emitters), the rifle will powerfully move
backwards and hit your shoulder hard. Their theory worked in practice. They did

2. 8/9/2017 8:35 PM Alpha Tau History Page 2 of 4
what every cancer scientist, every medical physicist, of their generation would say
is impossible. They did the impossible.
2003-2015: TheResults in Animals: At Tel Aviv University, Professors Kelson and
Keisari did pre-clinical trials in 6000 animals with many kinds of animal tumors
and over 12 different types of human tumors such as breast, prostate and head &
neck. The tumors weretreated under every conceivable condition, with and
without chemotherapy, with and without immuno-therapy. Someanimals had
only primary tumors; someweremetastasized, with cancer spread to distant
organs. In every case, the primary tumors weredissolved in days with no side
effects in the animals. In the metastasized animals, many experienced the positive
abscopaleffect, when the primary tumor (which keeps down the immune system)
was destroyed, the immune systemself-invigorated and destroyed the
metastases, and the cure was complete. Again, they did the impossible, being
successfulin every solid tumor.
How Was the Treatment Done?: The doctors inserted into the tumors a grid of
wires with 36 seeds, one every six millimeters, containing radioactiveradium 224,
a strong alpha particle emitter.
2015-2016: TheAmazing Deep Insight and its Aftermath: By 2015, the animal
trials werelargely done so it was time for human clinical trials. However, the great
work that had been done by the predecessor of ATM, Althera, under the CEO,
Leonard Gordon, had run out of money and steam. Howard Sterling was brought
in as advisor. Howard had a long-term friend, Uzi Sofer, who had justleft a long
term position as founder and CEO of Brainsway in Jerusalem, a pioneering leader
in trans-cranialmagnetic stimulation (TMS) which had received FDA approvalfor
treating depression. Uzihad at Brainsway doneover 100 human clinical trials and
set up a major sales force in the United States. Howard explained the alpha
particle technology to Uzi. Uzi then had a deep, amazing and moving insight. Uzi
explained that when he went to Brainsway every medical physicistknew that TMS
could only penetrate 1.5 centimeters in the brain no matter how powerfulthe
magnet, but his medical physicists showed how they could do the impossible,
magnetically penetrate 5-7 centimeters in the brain. Uzi said that Howard was
telling him that every medical physicistwould be surethat an alpha particle

3. 8/9/2017 8:35 PM Alpha Tau History Page 3 of 4
would only travel 1-2 microns fromits emitters and ProfessorsKelson and Keisari
could do the impossible, make an alpha particle effectively travel millimeters.
Howard affirmed that proposition. Uzi said he was in as CEO and fully committed.
Since then working tirelessly 24/6 Uzi has financed the company and broughton
board a great complement of management. His initial object was to begin human
clinical trials.
2017: The Results in Patients: In 2017, Alpha Tau Medical (ATM), an Israel
corporation under the leadership of Uzi Sofer as CEO, began very cautious Phase
1, safety-as-the-goal, clinical trials in patients at the Rabin Medical Center in
Israel. Thefirst three patients, done one at a time to make sureof safety, had
intractable squamous cellcarcinoma (SCC), head and neck cancer. Intractable
means neither conventional radiation nor chemotherapy could stop the growth of
the tumors which grew back quickly after surgery. SCCwas chosen as a model
systembecauseit is easy accessible. The therapy was entirely easy and safe. It
was done under local anesthesia. The patients wereawake. There were no side
effects and an immaterial, non-dangerous, amountof radiation escaped fromthe
tumor. The impossibleunique goal of safety, no side effects in a cancer therapy,
was reached. Unexpectedly, the doctors could see tumor shrinkageby 15 hours
after treatment, the tumors werecompletely gone in less than 10 days and the
surrounding tissuereturned to normal, no scars or inflammation.
Summary Achievements: ATM’s alpha particle therapy achieved a multitude of
impossibles. For the firsttime in cancer therapy, ATM attained a combination of:
Tumors dissolving in days;
· No side effects (there cannot be, sincethe alpha particles remain primarily
encapsulated in the tumor);
· Because of the rapid necrosis, therewas strong infiltration of a large number
of immune cells in the tumor beforeit was dissolved.
· No capital cost
· Very low costof goods;

4. 8/9/2017 8:35 PM Alpha Tau History Page 4 of 4
· Easy to administer;
· Works with one administration;
· Regulates as device so expect CE mark, enabling marketing in Europe and
other countries that regulate devices by the CE mark, by end of year.
The Future: The next set of clinical trials are meant to assess efficacy and safety.
These trials are to be carried out in Israeland 12 renowned institutions in Europe
and 12 institutions in the United States, led by Memorial Sloan Kettering Cancer
Center. The cancers to be trialed include SCC, recurrent prostatecancer,
inoperable breastcancer, colorectal cancer, recurrentgynecological cancer,
pancreatic cancer and recurrentcervical cancer. As compared to the usual
therapies, ATM’s alpha particles rely on physicsnot physiology. Thus wecan
hope/trustthat ATMs therapy will be efficacious in all solid tumors with a bonus
of no side effects, as they have been since2003.